The David vs. Goliath cannabis industry

In a deal worth over $2 billion, giant cannabis producer Cresco Labs is poised to acquire Columbia Care. This deal would expand Cresco’s retail presence to eighteen additional states. In short, Cresco Labs would become the leader in retail cannabis sales in North America.

Cresco Labs and Columbia Care are two of the top ten largest cannabis companies in North America. The acquisition of Columbia Care by its longtime competitor for over $2 billion will be one of the largest deals in the burgeoning legal global cannabis space. This business agreement will bring together two fundamental operators in the cannabis sector and create a new leader with the best of both companies. Columbia Care with its leading presence and Cresco Labs with its on-brand and competitive excellence. This fusion will be the envy of other top-of-the-line recordings in space.

Charles Bachtel, CEO of Cresco Labs, said the combination of the two companies lays the foundation for long-term growth on an unprecedented scale. The company will have sufficient diversification and depth. He described the partnership as “very complementary”. In its official statement, Bachtel promised that the combined entity would be the top-grossing cannabis company in and around the United States. He added that the company plans to conduct wholesale sales of customized cannabis products. On a pro pro forma basis, the Company will have the highest retail presence in Florida statewide.

A historic deal in the burgeoning cannabis industry

Columbia Care CEO Nicholas Vita commented that both companies will continue to put the interests of their stakeholders first, as they have always done since Columbia Care was founded. The cannabis industry is evolving and there are more and more opportunities to expand the space. Mr Nicholas explained that the merger of both companies would increase their chances of providing the best possible service to their customers and investors.

This is truly a historic moment for both companies, as well as for the North American cannabis industry as a whole. Vita stated that its strategic national presence in and around the country’s attractive cannabis markets would align well with Cresco’s unprecedented success in launching high-profile brands to establish North America’s best-known cannabis company. The merged entity will be the most investable in the ecosystem.

Important details of the sale

With this deal, Cresco Labs will have the highest pro-performa revenue in the U.S. cannabis industry at a valuation of $1.4 billion. The new company will have a foothold in at least 18 states. Experts predict that by 2025 the company will be the only wholesaler in the top 10 most important and fastest growing markets in the state. They are also said to meet the needs of over 50% of adult and medicinal cannabis users in the US.

Currently, Cresco Labs and Columbia Care are giants in their local cannabis markets. But this union of two giants will instantly kick-start the market. You’ll be in control of the legal cannabis markets in states like New Jersey, Maryland, Ohio, Pennsylvania, Virginia, New York and Florida. The two companies will have approximately 120 retail stores in 18 states. No other giant cannabis company can boast that.

BDSA, the leading market researcher and analyst in the North American cannabis industry, found that both companies represent the second largest retail presence of any multi-state operator (MSO). With the most extensive presence in Florida, BDSA also announced that the ongoing deal would increase the new company’s market share in each niche. For example, the company will now have market share for branded flowers, vapes, and concentrates. As such, Cresco Labs would remain one of the top five manufacturers of all cannabis products in Canada and the United States.

After announcing those sales, both companies’ shares rose, but both plummeted a few days later. Benzinga reported that Columbia Care stock is up at least 9% since January but is currently down about 60%. On the other hand, Cresco Labs, whose stock hit an all-time high in 2021, is down about 63%.

The newly formed company is expected to generate over $100 million in annual sales by the end of 2023. These sales are expected to increase as the combined company diversifies its products and expands its footprint and depth. Cresco alone has retail sales of about 47 percent. The merger of the two companies will increase sales by around 63 percent. There will be an increase in scale to improve profitability. Vertical integration is also expected to increase.

What to expect from this transaction

Cresco Labs has up to 50 retail stores. Each store generates $10.9 million in annual sales. This number is the highest of any national operator in the US cannabis industry. The deal with Columbia Care could add $500 million to the company’s marijuana asset sales. For the smooth acquisition of the Columbia Care, Cresco brand

Labs would have to sell about $400 worth of its retail and cultivation licenses to meet state licensing restrictions to smoothly acquire the Columbia Care brand. Cresco executives announced that the MSO would divest some of its five-state assets to eliminate overlaps with Columbia Care’s operations.

This large sale of assets between two of the cannabis industry’s top operators would create opportunities for other marijuana companies large and small. The merged company would rival other giants like Curaleaf Holdings and Trulieve Cannabis.

bottom line

Experts have analyzed Columbia Care’s sales to Cresco Labs. They commented that the merger would increase the value of the new company. However, there are also concerns that the merger could fail unexpectedly due to the massive divestment, approval and consent required for the transaction to be completed successfully.

A Cresco spokesman announced that a percentage of sales profits would be used to pay off outstanding debt. This is not Cresco’s first acquisition in recent years, but it is the most significant. Once the company has cleared the hurdle of divesting the necessary assets and obtaining approval from government regulators and shareholders, the acquisition will be completed.

NAVIGATION IN THE CANNABIS INDUSTRY, READ MORE..

NOW TROUBLE IN THE MARIJUANA BUSINESS INDUSTRY!